These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28807659)

  • 1. Expanding state laws and a growing role for pharmacists in vaccination services.
    Schmit CD; Penn MS
    J Am Pharm Assoc (2003); 2017; 57(6):661-669. PubMed ID: 28807659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?
    Trogdon JG; Shafer PR; Shah PD; Calo WA
    Vaccine; 2016 Aug; 34(38):4514-4519. PubMed ID: 27496275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Authority of Pharmacists to Administer Human Papillomavirus Vaccine: Alignment of State Laws With Age-Level Recommendations.
    Dingman DA; Schmit CD
    Public Health Rep; 2018; 133(1):55-63. PubMed ID: 29257933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on community pharmacies as CLIA-waived facilities.
    Adams AJ; Klepser ME; Klepser D
    Res Social Adm Pharm; 2016; 12(4):666-7. PubMed ID: 27138067
    [No Abstract]   [Full Text] [Related]  

  • 5. Encouraging comprehensive and consistent pharmacist education for provision of contraception.
    Anderson L; Borgelt LM; Clark P; Moore G
    J Am Pharm Assoc (2003); 2018; 58(1):113-116. PubMed ID: 29290339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' Patient Care Process: State "Scope of Practice" Priorities for Action.
    Adams AJ; Weaver KK
    Ann Pharmacother; 2021 Apr; 55(4):549-555. PubMed ID: 32787618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ending tobacco sales in pharmacies: A qualitative study.
    Jin Y; Berman M; Klein EG; Foraker RE; Lu B; Ferketich AK
    J Am Pharm Assoc (2003); 2017; 57(6):670-676.e1. PubMed ID: 28823544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges.
    Taitel MS; Fensterheim LE; Cannon AE; Cohen ES
    Am J Manag Care; 2013 Sep; 19(9):e309-13. PubMed ID: 24449960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
    Svensberg K; Sporrong SK; Björnsdottir I
    Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finance issue brief: any willing provider: year end report-2002.
    Morgan R; MacEachern L
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-10. PubMed ID: 12884878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention.
    Brewer NT; Chung JK; Baker HM; Rothholz MC; Smith JS
    Gynecol Oncol; 2014 Mar; 132 Suppl 1():S3-8. PubMed ID: 24361732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
    McConeghy KW; Wing C
    Vaccine; 2016 Jun; 34(30):3463-8. PubMed ID: 27219340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacy-based injectable naltrexone service delivery models and best practices.
    Ford JH; Gilson AM; Bryan G; Augustine C; Gassman M; Mott DA
    Res Social Adm Pharm; 2021 Jul; 17(7):1332-1341. PubMed ID: 33268242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
    Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
    BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.
    Kumar A; Ray AB; Blanchard C
    Health Res Policy Syst; 2022 Jan; 20(1):1. PubMed ID: 34980147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessibility of adult immunizations in pharmacies compared to physician offices in low-income communities.
    Popovian R; Winegarden W; Rivera E; Gavigan K
    J Am Pharm Assoc (2003); 2022; 62(5):1644-1647. PubMed ID: 35491381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Developments in Pharmacists' Scope of Practice to Address Unmet Health Care Needs.
    Burns AL
    Ann Pharmacother; 2016 Sep; 50(9):785-7. PubMed ID: 27340143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
    Pojskic N; MacKeigan L; Boon H; Austin Z
    Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pharmacist administration of influenza vaccines on uptake in Canada.
    Buchan SA; Rosella LC; Finkelstein M; Juurlink D; Isenor J; Marra F; Patel A; Russell ML; Quach S; Waite N; Kwong JC;
    CMAJ; 2017 Jan; 189(4):E146-E152. PubMed ID: 27503864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.